首頁 > 市場調查報告書 > 材料/化學品

市場調查報告書

商品編碼

2140275

類器官與球狀體：全球市場

Global Organoids and Spheroids Market

出版日期: 2026年09月15日 | 出版商:

BCC Research | 英文 110 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

本報告對全球類器官和球狀體市場進行了全面分析，涵蓋了關鍵趨勢、挑戰和市場發展。

本報告對2031年之前的市場規模進行了預測，並按產品類型、應用、最終用戶和地區對市場進行了分析。報告也探討了類器官和球狀體在藥物研發、個人化醫療、疾病研究、毒性測試、發育生物學和再生醫學的應用。除了製藥公司、生物技術公司、研究機構、合約研究組織（CRO）、醫院和診斷中心等主要最終用戶外，報告還涵蓋了競爭格局、市場佔有率以及領先企業的排名。

調查範圍

本報告分析並概述了全球類器官和球狀體市場的趨勢。該市場定義為透過銷售用於類器官和球狀體開發的產品和技術而獲得收入的公司，以及開發、培養和商業化類器官和球狀體模型的公司所產生的收入。

本報告包含以2025年為基準年的全球銷售額數據（單位：百萬美元），並對2026年估計值，同時預測至2031年。市場按產品類型、應用、最終用戶和地區進行細分。依產品類型分類，市場分為類器官和球狀體。按應用分類，市場分為藥物發現和個人化醫療、發育生物學、疾病病理學研究、藥物毒性和療效測試以及再生醫學。本研究涵蓋的地區包括北美、歐洲、亞太地區、南美以及中東和非洲，並聚焦於各地區的主要國家。

本報告重點關注影響市場和供應商格局的關鍵趨勢和挑戰。市場分析涵蓋了各類終端用戶對類器官和球狀體的應用情況，包括製藥和生物技術公司、學術和研究機構、受託研究機構(CRO)、醫院和診斷中心以及其他終端用戶。

本報告的最後部分分析了競爭格局，顯示了全球類器官和球狀體市場主要參與者的排名和市場佔有率。

報告內容

全球類器官和球狀體市場概覽。重點關注先進的3D細胞培養模型在生物醫學研究、藥物發現和精準醫療領域日益廣泛的應用。
除了 2025 年基準年的收入分析外，該報告還包括對主要區域市場 2026 年的市場估計和預測，以及到 2031 年的預測。
按類型、應用程式、最終用戶和地區分類的市場細分。
對影響類器官和球狀體技術全球傳播的關鍵成長要素、限制因素和新興機會進行分析。
深入了解技術進步，包括球狀體技術創新、CRISPR 整合、生物列印以及支援下一代研究模型的專利趨勢。
對北美、歐洲、亞太、南美以及中東和非洲進行區域評估，並對主要市場進行國別分析。
競爭格局分析，包括企業市場占有率分析、公司排名以及成熟公司和新興創新者的策略舉措。
主要市場企業的概況介紹。重點關注每家公司的業務概述、產品線和近期發展。

市場定義
類器官和球狀體概述
類器官與球狀體的比較
類器官和球狀體市場的未來發展方向
波特五力分析
新進入者的威脅（中等到高）
競爭強度
宏觀經濟因素分析
人口趨勢和疾病負擔
政府經費和研究投資
醫療保健成本和經濟成長
監理和倫理的變化
美伊衝突對類器官和球狀體市場的影響

第3章市場動態

市場動態
市場促進因素
與傳統的2D細胞培養相比，3D細胞培養模型的應用正在不斷擴大。
過渡到與人類高度相關的替代方法，以取代臨床前研究中的動物試驗。
擴大類器官和球狀體在癌症治療藥物發現的應用
市場限制因素
先進的3D細胞培養系統成本高昂
缺乏標準化流程和品管
可重複性挑戰
市場機遇
個人化醫療和精準腫瘤學的擴展
類器官在再生醫學和組織工程的應用日益廣泛。
自動化、高通量類器官平台的出現。

第4章監管情勢

概述
國家/地區特定法規和標準

第5章：新興技術與專利分析

概述
新興技術
3D球體工程技術的進步
將 CRISPR 和基因組編輯技術與類器官模型結合
3D生物列印技術在建構複雜類器官的興起
專利分析
年份
按管轄權

第6章市場區隔分析

細分市場
市場分析：依產品類型
類器官
球體
市場分析：按應用領域
藥物發現與個人化醫療
發育生物學
疾病的病理學研究
藥物毒性和療效測試
再生醫學
市場分析：依最終用戶分類
製藥和生物技術公司
學術研究機構
受託研究機構
醫院和診斷中心
其他最終用戶
按地區分類
市場分析：按地區分類
北美洲
歐洲
亞太地區
南美洲
中東和非洲

第7章競爭情勢

競爭格局
戰略分析

第8章附錄

調查方法
參考
簡稱
公司簡介
BIO-TECHNE
CORNING INC.
GREINER BIO-ONE INTERNATIONAL GMBH
INSPHERO
LONZA
MERCK KGAA
MOLECULAR DEVICES LLC.
REVVITY
STEMCELL TECHNOLOGIES
THERMO FISHER SCIENTIFIC INC.
新興創業公司/市場顛覆者

簡介目錄圖表

Product Code: BIO280A

The report examines the global organoids and spheroids market, covering key trends, challenges, and market developments. It provides market estimates through 2031 and analyzes the market by product type, application, end user, and region. The study also looks at the use of organoids and spheroids in drug discovery, personalized medicine, disease studies, toxicity testing, developmental biology, and regenerative medicine. It covers major end users, including pharmaceutical and biotechnology companies, research institutes, CROs, hospitals, and diagnostic centers, along with the competitive landscape, market shares, and rankings of key businesses.

Report Scope

This report provides an overview of the global organoids and spheroids market by analyzing its trends. The market is defined as the revenue generated by companies that derive their revenue from the sale of products and technologies used to develop organoids and spheroids, as well as companies that develop, grow, and commercialize organoid and spheroid models.

The report includes global revenue ($ millions), with 2025 as the base year, estimates for 2026, and forecasts through 2031. The market is segmented by product type, application, end user, and region. Based on product type, the market is categorized into organoid and spheroid. Based on applications, the market is segregated into drug discovery and personalized medicine, developmental biology, disease pathology studies, drug toxicity and efficacy testing, and regenerative medicine. The regions covered in this study are North America, Europe, Asia-Pacific, South America, and the Middle East and Africa, with a focus on major countries in each region.

The report focuses on the significant trends and challenges that affect the market and vendor landscape. The market analysis covers the adoption of organoids and spheroids by various end users, including pharmaceutical and biotechnology companies, academic and research institutes, contract research organizations, hospitals and diagnostic centers, and other end users.

The report concludes with an analysis of the competitive landscape, which provides rankings and market shares for key businesses in the global organoids and spheroids market.

Report Includes

Overview of the global organoids and spheroids market, highlighting the growing use of advanced 3D cell culture models in biomedical research, drug development, and precision medicine
Revenue analysis for the base year 2025, together with market estimates for 2026 and forecasts through 2031 across major regional markets
Breakdown of the market by type, application, end user, and region
Discussion of the major growth drivers, restraints, and emerging opportunities influencing the adoption of organoid and spheroid technologies worldwide
Insights into technological advancements, including innovations in spheroid technologies, CRISPR integration, bioprinting, and patent activity supporting next-generation research models
Regional assessment of North America, Europe, Asia-Pacific, South America, and the Middle East & Africa, with country-level analysis of leading markets
Competitive landscape review featuring market share analysis, company rankings, and strategic initiatives undertaken by established companies and emerging innovators
Profiles of leading market companies, highlighting their business overview, product offerings, and recent developments

Chapter 1 Executive Summary

Market Outlook
Scope of Report
Market Summary
Market Dynamics and Growth Factors
Emerging Technologies
Segmental Analysis
Regional Analysis
Conclusion

Chapter 2 Market Overview

Market Definition
Organoids and Spheroids Overview
Organoids Versus Spheroids
Future Directions in Organoids and Spheroids Market
Porter's Five Forces Analysis
Threat of New Entrants (Moderate)
Bargaining Power of Suppliers (Moderate to High)
Bargaining Power of Buyers (Moderate)
Threat of Substitutes (Moderate)
Level of Competitiveness (High)
Macroeconomic Factors Analysis
Demographic Trends and Disease Burden
Government Funding and Research Investments
Healthcare Expenditure and Economic Growth
Regulatory and Ethical Evolution
Impact of U.S.-Iran Conflict on the Organoids and Spheroids Market

Chapter 3 Market Dynamics

Market Dynamics
Market Drivers
Increasing Adoption of 3D Cell Culture Models Over Conventional 2D Cell Cultures
Shift Toward Human-Relevant Alternatives to Animal Testing in Preclinical Research
Rising Adoption of Organoids and Spheroids in Oncology Drug Discovery
Market Restraints
High Costs of Advanced 3D Cell Culture Systems
Lack of Standardized Protocols and Quality Control
Reproducibility Challenges
Market Opportunities
Expansion of Personalized Medicine and Precision Oncology
Growing Applications of Organoids in Regenerative Medicine and Tissue Engineering
Emergence of Automated High-Throughput Organoid Platforms

Chapter 4 Regulatory Landscape

Overview
Regulations and Standards by Country or Region

Chapter 5 Emerging Technologies and Patent Analysis

Overview
Emerging Technologies
Advances in 3D Spheroid Engineering Technologies
Integration of CRISPR and Genome Editing with Organoid Models
Emergence of 3D Bioprinting for Complex Organoid Assembly
Patent Analysis
By Year
By Jurisdiction

Chapter 6 Market Segmentation Analysis

Segmentation Breakdown
Market Analysis by Product Type
Key Takeaways
Organoids
Spheroids
Market Analysis by Application
Key Takeaways
Drug Discovery and Personalized Medicine
Developmental Biology
Disease Pathology Studies
Drug Toxicity and Efficacy Testing
Regenerative Medicine
Market Analysis by End User
Key Takeaways
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Contract Research Organizations
Hospitals and Diagnostic Centers
Other End Users
Geographic Breakdown
Market Analysis by Region
Key Takeaways
North America
Europe
Asia-Pacific
South America
Middle East and Africa

Chapter 7 Competitive Intelligence

Key Takeaways
Competitive Landscape
Strategic Analysis

Chapter 8 Appendix

Research Methodology
References
Abbreviations
Company Profiles
BIO-TECHNE
CORNING INC.
GREINER BIO-ONE INTERNATIONAL GMBH
INSPHERO
LONZA
MERCK KGAA
MOLECULAR DEVICES LLC.
REVVITY
STEMCELL TECHNOLOGIES
THERMO FISHER SCIENTIFIC INC.
A Few Emerging Startups/Market Disruptors

簡介目錄圖表

List of Tables

Summary Table : Global Market for Organoids and Spheroids, by Region, Through 2031
Table 1 : Difference between Organoids and Spheroids
Table 2 : Porter's Five Forces: Rating Scale
Table 3 : Estimated Cancer Incidence Cases, by Region, 2022-2045
Table 4 : Estimated Cancer Incidence Cases in Males in the U.S., by Cancer Site, 2025
Table 5 : Estimated Cancer Incidence Cases in Females in the U.S., by Cancer Site, 2025
Table 6 : Regulatory Landscape Governing Organoids and Spheroids Solutions, by Country or Region
Table 7 : Number of Patents, by Jurisdiction, 2024-2025
Table 8 : Global Market for Organoids and Spheroids, by Product Type, Through 2031
Table 9 : Global Market for Organoids, by Region, Through 2031
Table 10 : Global Market for Spheroids, by Region, Through 2031
Table 11 : Global Market for Organoids and Spheroids, by Application, Through 2031
Table 12 : Global Market for Organoids and Spheroids for Drug Discovery and Personalized Medicine, by Region, Through 2031
Table 13 : Global Market for Organoids and Spheroids for Developmental Biology, by Region, Through 2031
Table 14 : Global Market for Organoids and Spheroids for Disease Pathology Studies, by Region, Through 2031
Table 15 : Global Market for Organoids and Spheroids for Drug Toxicity and Efficacy Testing, by Region, Through 2031
Table 16 : Global Market for Organoids and Spheroids for Regenerative Medicine, by Region, Through 2031
Table 17 : Global Market for Organoids and Spheroids, by End User, Through 2031
Table 18 : Global Market for Organoids and Spheroids for Pharmaceutical and Biotechnology Companies, by Region, Through 2031
Table 19 : Global Market for Organoids and Spheroids for Academic and Research Institutes, by Region, Through 2031
Table 20 : Global Market for Organoids and Spheroids for Contract Research Organizations, by Region, Through 2031
Table 21 : Global Market for Organoids and Spheroids for Hospitals and Diagnostic Centers, by Region, Through 2031
Table 22 : Global Market for Organoids and Spheroids for Other End Users, by Region, Through 2031
Table 23 : Global Market for Organoids and Spheroids, by Region, Through 2031
Table 24 : North American Market for Organoids and Spheroids, by Country, Through 2031
Table 25 : North American Market for Organoids and Spheroids, by Product Type, Through 2031
Table 26 : North American Market for Organoids and Spheroids, by Application, Through 2031
Table 27 : North American Market for Organoids and Spheroids, by End User, Through 2031
Table 28 : European Market for Organoids and Spheroids, by Country, Through 2031
Table 29 : European Market for Organoids and Spheroids, by Product Type, Through 2031
Table 30 : European Market for Organoids and Spheroids, by Application, Through 2031
Table 31 : European Market for Organoids and Spheroids, by End User, Through 2031
Table 32 : Asia-Pacific Market for Organoids and Spheroids, by Country, Through 2031
Table 33 : Asia-Pacific Market for Organoids and Spheroids, by Product Type, Through 2031
Table 34 : Asia-Pacific Market for Organoids and Spheroids, by Application, Through 2031
Table 35 : Asia-Pacific Market for Organoids and Spheroids, by End User, Through 2031
Table 36 : South American Market for Organoids and Spheroids, by Country, Through 2031
Table 37 : South American Market for Organoids and Spheroids, by Product Type, Through 2031
Table 38 : South American Market for Organoids and Spheroids, by Application, Through 2031
Table 39 : South American Market for Organoids and Spheroids, by End User, Through 2031
Table 40 : MEA Market for Organoids and Spheroids, by Subregion, Through 2031
Table 41 : MEA Market for Organoids and Spheroids, by Product Type, Through 2031
Table 42 : MEA Market for Organoids and Spheroids, by Application, Through 2031
Table 43 : MEA Market for Organoids and Spheroids, by End User, Through 2031
Table 44 : Leading Providers of Organoids and Spheroids, 2025
Table 45 : Recent Developments in the Organoids and Spheroids Market, January 2024 to June 2026
Table 46 : Abbreviations Used in This Report
Table 47 : Bio-Techne: Company Snapshot
Table 48 : Bio-Techne: Financial Performance, FY 2023 and 2024
Table 49 : Bio-Techne: Product Portfolio
Table 50 : Corning Inc.: Company Snapshot
Table 51 : Corning Inc.: Financial Performance, FY 2024 and 2025
Table 52 : Corning Inc.: Product Portfolio
Table 53 : Corning Inc.: News/Key Developments, 2025
Table 54 : Greiner Bio-One International GmbH: Company Snapshot
Table 55 : Greiner Bio-One International GmbH: Product Portfolio
Table 56 : InSphero: Company Snapshot
Table 57 : InSphero: Product Portfolio
Table 58 : InSphero: News/Key Developments, 2024-2026
Table 59 : Lonza: Company Snapshot
Table 60 : Lonza: Financial Performance, FY 2024 and 2025
Table 61 : Lonza: Product Portfolio
Table 62 : Merck KGaA: Company Snapshot
Table 63 : Merck KGaA: Financial Performance, FY 2024 and 2025
Table 64 : Merck KGaA: Product Portfolio
Table 65 : Merck KGaA: News/Key Developments, 2025
Table 66 : Molecular Devices LLC.: Company Snapshot
Table 67 : Molecular Devices LLC.: Product Portfolio
Table 68 : Revvity: Company Snapshot
Table 69 : Revvity: Financial Performance, FY 2024 and 2025
Table 70 : Revvity: Product Portfolio
Table 71 : STEMCELL Technologies: Company Snapshot
Table 72 : STEMCELL Technologies: Product Portfolio
Table 73 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 74 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2024 and 2025
Table 75 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 76 : List of a Few Emerging Startups/Market Disruptors

List of Figures

Summary Figure : Global Market Shares for Organoids and Spheroids, by Region, 2025
Figure 1 : Porter's Five Forces Analysis: Organoids and Spheroids Market
Figure 2 : Market Dynamics of Organoids and Spheroids
Figure 3 : Emerging Technologies in the Organoids and Spheroids Market
Figure 4 : Total Number of Patents, by Year, 2024 and 2025
Figure 5 : Global Market Shares for Organoids and Spheroids, by Product Type, 2025
Figure 6 : Global Market Shares for Organoids, by Region, 2025
Figure 7 : Global Market Shares for Organoids, by Type, 2025
Figure 8 : Global Market Shares for Spheroids, by Region, 2025
Figure 9 : Global Market Shares for Spheroids, by Type, 2025
Figure 10 : Global Market Shares for Organoids and Spheroids, by Application, 2025
Figure 11 : Global Market Shares for Organoids and Spheroids for Drug Discovery and Personalized Medicine, by Region, 2025
Figure 12 : Global Market Shares for Organoids and Spheroids for Developmental Biology, by Region, 2025
Figure 13 : Global Market Shares for Organoids and Spheroids for Disease Pathology Studies, by Region, 2025
Figure 14 : Global Market Shares for Organoids and Spheroids for Drug Toxicity and Efficacy Testing, by Region, 2025
Figure 15 : Global Market Shares for Organoids and Spheroids for Regenerative Medicine, by Region, 2025
Figure 16 : Global Market Shares for Organoids and Spheroids, by End User, 2025
Figure 17 : Global Market Shares for Organoids and Spheroids for Pharmaceutical and Biotechnology Companies, by Region, 2025
Figure 18 : Global Market Shares for Organoids and Spheroids for Academic and Research Institutes, by Region, 2025
Figure 19 : Global Market Shares for Organoids and Spheroids for Contract Research Organizations, by Region, 2025
Figure 20 : Global Market Shares for Organoids and Spheroids for Hospitals and Diagnostic Centers, by Region, 2025
Figure 21 : Global Market Shares for Organoids and Spheroids for Other End Users, by Region, 2025
Figure 22 : Global Market Shares for Organoids and Spheroids, by Region, 2025
Figure 23 : North American Market Shares for Organoids and Spheroids, by Country, 2025
Figure 24 : European Market Shares for Organoids and Spheroids, by Country, 2025
Figure 25 : Asia-Pacific Market Shares for Organoids and Spheroids, by Country, 2025
Figure 26 : South American Market Shares for Organoids and Spheroids, by Country, 2025
Figure 27 : MEA Market Shares for Organoids and Spheroids, by Subregion, 2025
Figure 28 : Bio-Techne: Revenue Share, by Business Unit, FY 2024
Figure 29 : Bio-Techne: Revenue Share, by Country/Region, FY 2024
Figure 30 : Corning Inc.: Revenue Shares, by Business Unit, FY 2025
Figure 31 : Corning Inc.: Revenue Shares, by Country/Region, FY 2025
Figure 32 : Lonza: Revenue Shares, by Business Unit, FY 2025
Figure 33 : Lonza: Revenue Shares, by Country/Region, FY 2025
Figure 34 : Merck KGaA: Revenue Share, by Business Unit, FY 2025
Figure 35 : Merck KGaA: Revenue Share, by Country/Region, FY 2025
Figure 36 : Revvity: Revenue Shares, by Business Unit, FY 2025
Figure 37 : Revvity: Revenue Shares, by Country/Region, FY 2025
Figure 38 : Thermo Fisher Scientific Inc.: Revenue Shares, by Business Unit, FY 2025
Figure 39 : Thermo Fisher Scientific Inc.: Revenue Shares, by Country/Region, FY 2025